Chronic Kidney Disease Progress

Healthy People 2010 Focus Area 4: Chronic Kidney Disease Progress Review September 21, 2006 Status of Chronic Kidney Disease Objectives 4-1. End-stage renal disease 4-2. Cardiovascular disease deaths in persons with chronic kidney failure 4-3. Counseling for chronic kidney failure care 4-4. Use of arteriovenous fistulas 4-5. Registration for kidney transplantation 4-6. Waiting time for kidney transplantation 4-7. End-stage renal disease due to diabetes 4-8a. Medical evaluation for persons with type 1 or type 2 diabetes and chronic kidney disease 4-8b. Medical treatment for persons with type 1 or type 2 diabetes and chronic kidney disease Target met Improving Getting worse Baseline data only End-stage Renal Disease, By Race/Hispanic Origin Incidence rate per 1,000,000 population 1,200 1,000 800 600 Hispanic Black American Indian 400 Asian Total White 2010 Target 200 0 1997 1998 1999 2000 2001 2002 2003 2004 Obj. 4-1 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. End-stage Renal Disease Due to Diabetes, By Race/Hispanic Origin Incidence rate per 1,000,000 population 1,200 1,000 800 600 American Indian Black 400 200 Total Hispanic Asian White 2010 Target 0 1997 1998 1999 2000 2001 2002 2003 2004 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Obj. 4-7 ESRD and ESRD Due to Diabetes, By Race/Hispanic Origin End-stage Renal Disease Incidence rate per million 1,200 1,000 End-stage Renal Disease Due to Diabetes 1,200 1,000 Black American Indian 800 600 400 800 600 Asian American Indian Hispanic 2010 Target Black Hispanic Total White 2010 Target 200 0 Total 400 White 200 0 Asian 1997 1998 1999 2000 2001 2002 2003 2004 1997 1998 1999 2000 2001 2002 2003 2004 Obj. 4-1 Obj. 4-7 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. End-stage Renal Disease, By Race and Gender Incidence rate per 1,000,000 1998-2000 2001-2003 Men American Indian Asian 2010 Target Black White Women American Indian Asian Black White 0 200 400 600 800 1,000 1,200 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Obj. 4-1 End-stage Renal Disease, By Health Service Area, 1993 Incidence rate per 1,000,000 population SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Obj. 4-1 End-stage Renal Disease, By Health Service Area, 2003 Incidence rate per 1,000,000 population SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Obj. 4-1 End-stage Renal Disease Due to Diabetes, By Gender Incidence rate per 1,000,000 population 200 180 160 Males Total Females 140 120 100 80 60 2010 Target 40 20 0 1997 1998 1999 2000 2001 2002 2003 2004 Obj. 4-7 SOURCE:United States Renal Data System (USRDS), NIH, NIDDK. Percent 80 70 60 50 40 30 20 10 0 Use of Arteriovenous Fistulas* Among the Newly Diagnosed By Race/Hispanic Origin American Indian 2010 Target Asian White Hispanic Total Black 1998 1999 2000 2001 2002 2003 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. The categories black and white exclude persons of Hispanic origin. Persons of Hispanic origin may be any race. SOURCE: Centers for Medicare and Medicaid Services (CMS) Clinical Performace Measures (CPM) project. Obj. 4-4 Percent 60 50 40 Use of Arteriovenous Fistulas Among the Newly Diagnosed By Gender 2010 Target Males Total 30 20 Females 10 0 1998 1999 2000 2001 2002 2003 SOURCE: Centers for Medicare and Medicaid Services (CMS) Clinical Performance Measures (CPM) project. Obj. 4-4 Medical Evaluation for Persons with Diabetes and Chronic Kidney Disease Percent 60 50 40 Black White Asian Hispanic 2010 Target 30 20 10 0 American Indian 2000 2001 2002 2003 2004 Obj. 4-8a Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. Only one race category could be recorded. Recording more than one race was not an option. SOURCE: Centers for Medicare and Medicaid Services (CMS); United States Renal Data System (USRDS), NIH, NIDDK. Medical Evaluation for Persons with Diabetes and Chronic Kidney Disease Percent 60 50 40 Black Medical evaluation include eye examinations, lipid testing, and glycosylated hemoglobin (HbA1c) testing White Asian Hispanic 2010 Target 30 20 10 0 American Indian 2000 2001 2002 2003 2004 Obj. 4-8a Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. Only one race category could be recorded. Recording more than one race was not an option. SOURCE: Centers for Medicare and Medicaid Services (CMS); United States Renal Data System (USRDS), NIH, NIDDK. Medical Treatment for Persons with Diabetes and Chronic Kidney Disease 2000 Total 2010 Target American Indian * Asian Native Hawaiian Black White Hispanic * * * 10 Percent 0 20 30 40 Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: USRDS. Obj. 4-8b Medical Treatment for Persons with Diabetes and Chronic Kidney Disease Medical treatment includes the use of angiotensin converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) 2000 Total 2010 Target American Indian * Asian Native Hawaiian Black White Hispanic * * * 10 Percent 0 20 30 40 Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: USRDS. Obj. 4-8b Progress review data and slides are available on the web at: http://www.cdc.gov/nchs/hphome.htm